Compare Morgan Stanley (MS) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Morgan Stanley vs Teladoc Health Inc — how do they compare? Morgan Stanley trades at $214.68 (market cap $338.50B), while Teladoc Health Inc trades at $6.83 (market cap $1.29B). The key difference: Morgan Stanley is far larger — about 262.4× Teladoc Health Inc's market cap, and Morgan Stanley pays a 2.14% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals.
| MS | TDOC | |
|---|---|---|
Market Cap | $338.50B | $1.29B |
Sector | Financials | Health |
52-Week High | $228.42 | $9.72 |
52-Week Low | $143.88 | $4.47 |
Dividend Yield | 2.14% | — |
Enterprise Value | — | $1.55B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Morgan Stanley (MS) trades at $215.1, down 0.54% on the day, with a neutral technical signal and key support at $214. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $3.46 surpassing expectations of $2.89. Revenue growth accelerated to $66.0B in 2025, and net income margin improved to 25.56%. Recent news highlights Morgan Stanley's role in leading Anthropic's IPO and expanding AI integration in wealth management.
The outlook remains positive with a consensus price target of $239.58, implying 11% upside. Strengths include robust profitability and strategic initiatives, but risks involve volatile cash flows from operations and high leverage. Analyst sentiment is bullish with 56% buy ratings, though investors should monitor debt levels and market volatility.
TDOC trades at $7.13, up 6.74% in the last session, but remains under pressure after a 28% drop in August 2026 due to a revenue miss and lowered guidance. The stock shows oversold technical signals with RSI near 24, while fundamentals reveal a net loss margin of -7.13% despite a gross margin of 68.97%. Recent news highlights multiple law firm investigations into securities claims, adding to investor uncertainty.
The outlook is cautious; analyst consensus is a hold with a $8.88 price target, but risks include ongoing losses, competitive pressures, and legal scrutiny. Upside depends on execution in integrated care, but near-term volatility is high.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Morgan Stanley
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments. The company had about $5 trillion of client assets as well as over 70,000 employees at the end of 2021. Approximately 50% of the company's net revenue is from its institutional securities business, with the remainder coming from wealth and investment management. The company derives about 30% of its total revenue outside the Americas.
Read more on MS →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
